Skip to content

Total Assets at other companies

Eli Lilly logo
Eli LillyLLY
$116.58B+30.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$200.89B+3.7%
Amgen logo
AmgenAMGN
$92.5B+3.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$40.87B+8.9%
Janux Therapeutics logo
Janux TherapeuticsJANX
$1.03B-2.1%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$763.27M+198%

Other financials

Income statement

See full
Revenue-
Operating income-$53.7M+2.4%
Net income-$49.7M-2.4%
EPS (diluted)-$0.69+24.2%

Balance sheet

See full
Cash & equivalents$75.1M-2.1%
Total debt$2.4M+29.5%
Total equity$408.7M-30.8%

Cash flow

See full
Operating cash flow-$46.0M-6.7%
CapEx$11.0K
Free cash flow-$38.1M-4.1%

Valuation

See full
Market cap$1.08B+140%
Enterprise value$1.01B+168%

Profitability

See full
Operating margin-358.7%
Net margin-346.1%

Returns & leverage

See full
Return on equity-44%+26.2pp
Debt / equity0.0×
Current ratio10.3×-1.3×

Where this comes from

Reported directly by Cullinan Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cullinan Therapeutics, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cullinan Therapeutics, Inc.'s total assets?
Cullinan Therapeutics, Inc. (CGEM) reported total assets of $402.98M in Q1 2026.
How has Cullinan Therapeutics, Inc.'s total assets changed year-over-year?
Cullinan Therapeutics, Inc.'s total assets decreased by 30.5% year-over-year, from $579.68M to $402.98M.
What is the long-term trend for Cullinan Therapeutics, Inc.'s total assets?
Over 5 years (2020 to 2025), Cullinan Therapeutics, Inc.'s total assets has grown at a 15.9% compound annual growth rate (CAGR), from $214.71M to $448.37M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.